Curran Simpson, Chief Executive Officer at REGENXBIO Inc. (RGNX), sold 100 shares at $15.00 ($2K) on 2024-08-01, disclosed to the SEC on 2024-08-05.
Scheduled sale ($2k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGNX | SELL | 2025-09-12 | $155K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |
| RGNX | SELL | 2021-01-14 | $1.2M | — | Filing → |